PMID- 38537063 OWN - NLM STAT- Publisher LR - 20240327 IS - 1538-943X (Electronic) IS - 1058-2916 (Linking) DP - 2024 Mar 28 TI - Impella as Bridge to Durable Left Ventricular Assist Device in Acute Myocardial Infarction Cardiogenic Shock Patients. LID - 10.1097/MAT.0000000000002201 [doi] AB - Implantation of durable left ventricular assist device (LVAD) in cardiogenic shock (CS) patients after acute myocardial infarction (AMI) poses specific challenges (small left ventricular size, acute infarct area, need for antithrombotic therapy, status Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 with impaired organ function and derangements in coagulation and inflammatory parameters) which may affect outcomes. We reviewed data of all AMI-CS patients who were implanted LVAD after Impella support at a referral center with the aim to analyze feasibility, timing, and outcomes of durable LVAD implantation after tMCS with Impella due to AMI-CS. Twenty-one patients were treated between 2013 and 2023: all were in Society for Cardiovascular Angiography & Interventions (SCAI) class D-E and INTERMACS 1-2 at presentation, median LV ejection fraction (EF) and LV end-diastolic diameter (EDD) were 15 (10-20)% and 57 (54-60) mm, respectively. Eleven patients (52%) were supported with Impella CP, seven with Impella 5.0 (33%), and three (14%) with Impella 2.5. Axillary cannulation was performed in nine patients (43%). Five patients (24%) had concomitant venoarterial extracorporeal membrane oxygenation (VA-ECMO) support. Median duration of Impella support was 12 (8-14) days. Overall, the use of Impella was characterized by low rate of complications and allowed successful bridge to durable LVAD in all patients, with 100% 30 day survival rate. CI - Copyright (c) ASAIO 2024. FAU - Ajello, Silvia AU - Ajello S AD - From the Cardiac Intensive Care Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy. FAU - Pieri, Marina AU - Pieri M AUID- ORCID: 0000-0002-4101-800 AD - Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan Italy. AD - School of Medicine, Vita-Salute San Raffaele University, Milan, Italy. FAU - Dormio, Sara AU - Dormio S AD - Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan Italy. FAU - Baldetti, Luca AU - Baldetti L AD - From the Cardiac Intensive Care Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy. FAU - Altizio, Savino AU - Altizio S AD - From the Cardiac Intensive Care Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy. FAU - Consolo, Filippo AU - Consolo F AD - School of Medicine, Vita-Salute San Raffaele University, Milan, Italy. FAU - Nardelli, Pasquale AU - Nardelli P AD - Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan Italy. FAU - Ortalda, Alessandro AU - Ortalda A AD - Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan Italy. FAU - Scandroglio, Anna Mara AU - Scandroglio AM AD - Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan Italy. LA - eng PT - Journal Article DEP - 20240328 PL - United States TA - ASAIO J JT - ASAIO journal (American Society for Artificial Internal Organs : 1992) JID - 9204109 SB - IM COIS- Disclosure: M.P., S. Alticcio, P.N., A.O., and A.M.S. received speaker fee by Abiomed GmbH. M.P. received consultancy fee by Abiomed GmbH. The other authors have no conflicts of interest to report. EDAT- 2024/03/27 18:45 MHDA- 2024/03/27 18:45 CRDT- 2024/03/27 15:23 PHST- 2024/03/27 18:45 [medline] PHST- 2024/03/27 18:45 [pubmed] PHST- 2024/03/27 15:23 [entrez] AID - 00002480-990000000-00452 [pii] AID - 10.1097/MAT.0000000000002201 [doi] PST - aheadofprint SO - ASAIO J. 2024 Mar 28. doi: 10.1097/MAT.0000000000002201.